ArticleOrphanet journal of rare diseases2025
Neurocognitive function in males with 46,XX testicular difference of sex development.
Article in Orphanet journal of rare diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A Case of de la Chapelle Syndrome.Cureus · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
background46,XX testicular difference of sex development (46,XX T-DSD) is a rare condition, in which individuals with a typical female chromosomal pattern (46,XX) present with a male phenotype. Although neurocognitive function has previously been reported as normal in males with 46,XX T-DSD, studies indicate potential neurocognitive challenges, including lower educational attainment.
objectiveWe aimed to assess neurocognitive function in males with 46,XX T-DSD compared to 46,XY male controls using the Wechsler Adult Intelligence Scale, Fourth Edition (WAIS-IV).
methods47 participants were included in the study, comprising 25 males with 46,XX T-DSD and 22 46,XY male controls matched on age and educational level. Of the 25 46,XX T-DSD males, 23 had an SRY translocation, while the remaining two were SRY-negative; one of these showed a SOX9 duplication, and no genetic cause was identified for the other despite extensive testing. All participants completed the WAIS-IV. We calculated each participant's Full-Scale Intelligence Quotient (FSIQ) and four index scores: Verbal Comprehension Index, Perceptual Reasoning Index, Working Memory Index, and Processing Speed Index.
resultsMales with 46,XX T-DSD scored significantly lower on the Working Memory Index (mean ± SD: 93.3 ± 15.7 vs. 104.3 ± 14.6, p = 0.017) compared to controls, with two of three subtests showing lower scores (p < 0.05). In the 46,XX T-DSD group, mean scores on the Verbal Comprehension Index and overall FSIQ were 91.6 ± 16.7 and 93.8 ± 15.6, respectively, compared with 98.9 ± 11.4 and 100.7 ± 10.3 in controls. Neither difference reached statistical significance (VCI: p = 0.092, FSIQ: p = 0.086). All mean scores for both groups remained within the normal range. Among males with 46,XX T-DSD, 56% (n = 14) scored in the low average range (80-89) or below on the FSIQ, compared to only 13.6% (n = 3) in the control group. Additionally, two males in the 46,XX T-DSD group scored in the extremely low range (≤ 69), whereas none in the control group did.
conclusionOur findings indicate that 46,XX T-DSD males score significantly lower on the Working Memory Index compared to controls. No other statistically significant differences in index scores were observed, and all mean scores for both groups remained within the normal range. Larger-scale research and more comprehensive assessments of non-cognitive factors will be essential for gaining deeper insight into these findings and assessing their clinical significance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.